首页 > 最新文献

Journal of Ophthalmic & Vision Research最新文献

英文 中文
Krill's Disease: A Newer Management Option. 磷虾病:一个新的管理选择。
IF 2 Q3 OPHTHALMOLOGY Pub Date : 2023-07-01 DOI: 10.18502/jovr.v18i3.13782
Sarang P Lambat, Vinay B Nangia, Prabhat V Nangia, Neha H Shah, Swati D Mishra

Purpose: To report a case of a young female who presented with scotoma in the right eye for few days.

Case report: Krill's disease or acute retinal pigment epithelitis (ARPE) is a self-limiting retinal disease with no specific treatment. Typical clinical and imaging features helped us to diagnose her with ARPE. Intravenous methylprednisolone (IVMP), which gives a rapid anti-inflammatory response, was advised. An SD-OCT scan post-injection showed a reduction in hyperreflectivity and height of lesion at day 3 and near total resolution by day 5.

Conclusion: This case suggests rapid resolution of ARPE with the use of IVMP.

目的:报告一例年轻女性右眼出现暗斑数天的病例。病例报告:磷虾病或急性视网膜色素上皮炎(ARPE)是一种无特异性治疗的自限性视网膜疾病。典型的临床和影像学特征帮助我们诊断为ARPE。建议静脉注射甲基强的松龙(IVMP),它能迅速产生抗炎反应。注射后的SD-OCT扫描显示,第3天高反射率和病变高度降低,第5天接近完全分辨。结论:本病例提示IVMP能快速解决ARPE。
{"title":"Krill's Disease: A Newer Management Option.","authors":"Sarang P Lambat,&nbsp;Vinay B Nangia,&nbsp;Prabhat V Nangia,&nbsp;Neha H Shah,&nbsp;Swati D Mishra","doi":"10.18502/jovr.v18i3.13782","DOIUrl":"https://doi.org/10.18502/jovr.v18i3.13782","url":null,"abstract":"<p><strong>Purpose: </strong>To report a case of a young female who presented with scotoma in the right eye for few days.</p><p><strong>Case report: </strong>Krill's disease or acute retinal pigment epithelitis (ARPE) is a self-limiting retinal disease with no specific treatment. Typical clinical and imaging features helped us to diagnose her with ARPE. Intravenous methylprednisolone (IVMP), which gives a rapid anti-inflammatory response, was advised. An SD-OCT scan post-injection showed a reduction in hyperreflectivity and height of lesion at day 3 and near total resolution by day 5.</p><p><strong>Conclusion: </strong>This case suggests rapid resolution of ARPE with the use of IVMP.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 3","pages":"334-338"},"PeriodicalIF":2.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432932/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10106038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Characteristics and Outcomes of Endophthalmitis Before and During the COVID-19 Pandemic. 2019冠状病毒病大流行前后眼内炎的临床特点及转归
IF 2 Q3 OPHTHALMOLOGY Pub Date : 2023-07-01 DOI: 10.18502/jovr.v18i3.13777
Blake H Fortes, Prashant D Tailor, Timothy T Xu, Robert A Churchill, Matthew R Starr

Purpose: To evaluate the clinical characteristics and visual acuity outcomes of patients who presented with endophthalmitis prior to and during the coronavirus disease 2019 (COVID-19) pandemic.

Methods: This multicenter retrospective case series with historical controls included consecutive patients presenting with any form of endophthalmitis from March 1, 2019 to September 1, 2019 (pre-COVID-19) and from March 1, 2020 to September 1, 2020 (COVID-19) at Mayo Clinic Rochester (MCR), Health System (MCHS), Arizona (MCA), and Florida (MCF) sites. Cases were divided into "pre-COVID-19" versus "COVID-19" groups depending on when they first presented with endophthalmitis.

Results: Twenty-eight cases of endophthalmitis presented to all Mayo Clinic sites during the study period. Of these, 10 patients presented during the first six months of the COVID-19 pandemic. During the same six-month period the year prior, 18 patients presented with endophthalmitis. Endophthalmitis etiology (post-injection, post-cataract extraction, post-glaucoma filtering surgery, post-pars plana vitrectomy, endogenous, and others) was similar between both groups (P = 0.34), as was post-injection endophthalmitis rate (P = 0.69), days to presentation (P = 0.07), initial management (P = 0.11), culture-positivity rate (P = 0.70), and need for subsequent pars plana vitrectomy (P = 1). Visual acuity outcomes were similar between both groups at six months, however, the mean LogMAR visual acuity at presentation was worse in the COVID-19 group compared to the pre-COVID-19 group (2.44 vs 1.82; P = 0.026).

Conclusion: Clinical characteristics and the post-injection endophthalmitis rate were similar during both periods, however, patients presented with worse vision during the pandemic suggesting that the pandemic may have contributed to delayed presentation, regardless, outcomes are still poor.

目的:评价2019冠状病毒病(COVID-19)大流行前和期间出现眼内炎患者的临床特征和视力结局。方法:该多中心回顾性病例系列纳入了2019年3月1日至2019年9月1日(COVID-19前期)和2020年3月1日至2020年9月1日(COVID-19)在梅奥诊所罗切斯特(MCR)、卫生系统(MCHS)、亚利桑那州(MCA)和佛罗里达州(MCF)连续出现的任何形式的眼内炎患者。根据患者首次出现眼内炎的时间,将患者分为“COVID-19前”组和“COVID-19”组。结果:研究期间梅奥诊所共收治28例眼内炎病例。其中,10名患者是在COVID-19大流行的前六个月出现的。在前一年相同的六个月期间,18名患者出现眼内炎。两组眼内炎的病因(注射后、白内障摘除后、青光眼滤过手术后、睫状体部切除术后、内源性等)相似(P = 0.34),注射后眼内炎发生率(P = 0.69)、发病天数(P = 0.07)、初始处理(P = 0.11)、培养阳性率(P = 0.70)和后续睫状体部切除术的必要性(P = 1)也相似。然而,两组6个月时的视力结果相似。与COVID-19前组相比,COVID-19组的平均LogMAR视力更差(2.44 vs 1.82;P = 0.026)。结论:两个时期的临床特征和注射后眼内炎发生率相似,然而,患者在大流行期间表现出更差的视力,这表明大流行可能导致延迟出现,无论如何,结果仍然很差。
{"title":"Clinical Characteristics and Outcomes of Endophthalmitis Before and During the COVID-19 Pandemic.","authors":"Blake H Fortes,&nbsp;Prashant D Tailor,&nbsp;Timothy T Xu,&nbsp;Robert A Churchill,&nbsp;Matthew R Starr","doi":"10.18502/jovr.v18i3.13777","DOIUrl":"https://doi.org/10.18502/jovr.v18i3.13777","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the clinical characteristics and visual acuity outcomes of patients who presented with endophthalmitis prior to and during the coronavirus disease 2019 (COVID-19) pandemic.</p><p><strong>Methods: </strong>This multicenter retrospective case series with historical controls included consecutive patients presenting with any form of endophthalmitis from March 1, 2019 to September 1, 2019 (pre-COVID-19) and from March 1, 2020 to September 1, 2020 (COVID-19) at Mayo Clinic Rochester (MCR), Health System (MCHS), Arizona (MCA), and Florida (MCF) sites. Cases were divided into \"pre-COVID-19\" versus \"COVID-19\" groups depending on when they first presented with endophthalmitis.</p><p><strong>Results: </strong>Twenty-eight cases of endophthalmitis presented to all Mayo Clinic sites during the study period. Of these, 10 patients presented during the first six months of the COVID-19 pandemic. During the same six-month period the year prior, 18 patients presented with endophthalmitis. Endophthalmitis etiology (post-injection, post-cataract extraction, post-glaucoma filtering surgery, post-pars plana vitrectomy, endogenous, and others) was similar between both groups (<i>P</i> = 0.34), as was post-injection endophthalmitis rate (<i>P</i> = 0.69), days to presentation (<i>P</i> = 0.07), initial management (<i>P</i> = 0.11), culture-positivity rate (<i>P</i> = 0.70), and need for subsequent pars plana vitrectomy (<i>P</i> = 1). Visual acuity outcomes were similar between both groups at six months, however, the mean LogMAR visual acuity at presentation was worse in the COVID-19 group compared to the pre-COVID-19 group (2.44 vs 1.82; <i>P</i> = 0.026).</p><p><strong>Conclusion: </strong>Clinical characteristics and the post-injection endophthalmitis rate were similar during both periods, however, patients presented with worse vision during the pandemic suggesting that the pandemic may have contributed to delayed presentation, regardless, outcomes are still poor.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 3","pages":"289-296"},"PeriodicalIF":2.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432927/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10106042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diffuse Pigment Release in a Patient Undergoing Tumor-Infiltrating Lymphocyte Immunotherapy for Acral Malignant Melanoma. 一名接受肿瘤浸润性淋巴细胞免疫治疗的肢端恶性黑色素瘤患者弥漫性色素释放。
IF 2 Q3 OPHTHALMOLOGY Pub Date : 2023-07-01 DOI: 10.18502/jovr.v18i3.13783
Madison Kerley, Niloofar Piri, Aparna Ramasubramanian
This is a Photo Essay and does not have an abstract. Please download the PDF or view the article in HTML.
{"title":"Diffuse Pigment Release in a Patient Undergoing Tumor-Infiltrating Lymphocyte Immunotherapy for Acral Malignant Melanoma.","authors":"Madison Kerley,&nbsp;Niloofar Piri,&nbsp;Aparna Ramasubramanian","doi":"10.18502/jovr.v18i3.13783","DOIUrl":"https://doi.org/10.18502/jovr.v18i3.13783","url":null,"abstract":"This is a Photo Essay and does not have an abstract. Please download the PDF or view the article in HTML.","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 3","pages":"339-341"},"PeriodicalIF":2.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432936/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10106040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bilateral Giant Full Thickness Macular Holes: An Infrequent Manifestation of Alport Syndrome. 双侧巨大全层黄斑孔:Alport综合征的罕见表现。
IF 2 Q3 OPHTHALMOLOGY Pub Date : 2023-07-01 DOI: 10.18502/jovr.v18i3.13781
Saeed Karimi, Niloofar Mohammad Bagheri Rafsanjani

Purpose: To report a case of Alport syndrome presenting with bilateral giant full-thickness macular holes, hypertensive chorioretinopathy, and exudative retinal detachment.

Case report: A 20 year-old man, a known case of Alport syndrome on hemodialysis, was referred to our clinic with bilateral vision loss initiated about 10 years prior to presentation, which exacerbated in the month prior to our visit. Bilateral large full-thickness macular holes, hypertensive chorioretinopathy, and exudative retinal detachment were detected in fundus examination. The patient had previous genetic counseling confirming the diagnosis of Alport syndrome. During follow-up, macular holes were covered with a thick epiretinal membrane and visual acuity decreased progressively in two weeks. Pars plana vitrectomy was performed in the right eye. Two weeks following surgery, the macular hole was closed and visual acuity improved significantly.

Conclusion: Bilateral giant full-thickness macular holes are uncommon presentations of Alport syndrome. The retinal findings may be caused by an inefficient type IV collagen presenting in the Bruch's membrane and in the internal limiting membrane. Pars plana vitrectomy can be considered to repair macular holes in these patients.

目的:报告一例以双侧巨大全层黄斑孔、高血压性脉络膜视网膜病变和渗出性视网膜脱离为主要表现的Alport综合征。病例报告:一名20岁男性,已知的血液透析阿尔波特综合征病例,在就诊前10年左右开始双侧视力丧失,在就诊前一个月加重。眼底检查发现双侧全层黄斑大孔、高血压性脉络膜视网膜病变、渗出性视网膜脱离。患者先前进行过遗传咨询,确认诊断为Alport综合征。随访期间,黄斑孔被一层较厚的视网膜前膜覆盖,视力在两周内逐渐下降。右眼行玻璃体切除。术后2周,黄斑孔闭合,视力明显改善。结论:双侧巨大全层黄斑孔是Alport综合征的罕见表现。视网膜的发现可能是由于低效的IV型胶原蛋白呈现在布鲁氏膜和内限制膜。这些患者可考虑行玻璃体切除术来修复黄斑孔洞。
{"title":"Bilateral Giant Full Thickness Macular Holes: An Infrequent Manifestation of Alport Syndrome.","authors":"Saeed Karimi,&nbsp;Niloofar Mohammad Bagheri Rafsanjani","doi":"10.18502/jovr.v18i3.13781","DOIUrl":"https://doi.org/10.18502/jovr.v18i3.13781","url":null,"abstract":"<p><strong>Purpose: </strong>To report a case of Alport syndrome presenting with bilateral giant full-thickness macular holes, hypertensive chorioretinopathy, and exudative retinal detachment.</p><p><strong>Case report: </strong>A 20 year-old man, a known case of Alport syndrome on hemodialysis, was referred to our clinic with bilateral vision loss initiated about 10 years prior to presentation, which exacerbated in the month prior to our visit. Bilateral large full-thickness macular holes, hypertensive chorioretinopathy, and exudative retinal detachment were detected in fundus examination. The patient had previous genetic counseling confirming the diagnosis of Alport syndrome. During follow-up, macular holes were covered with a thick epiretinal membrane and visual acuity decreased progressively in two weeks. Pars plana vitrectomy was performed in the right eye. Two weeks following surgery, the macular hole was closed and visual acuity improved significantly.</p><p><strong>Conclusion: </strong>Bilateral giant full-thickness macular holes are uncommon presentations of Alport syndrome. The retinal findings may be caused by an inefficient type IV collagen presenting in the Bruch's membrane and in the internal limiting membrane. Pars plana vitrectomy can be considered to repair macular holes in these patients.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 3","pages":"328-333"},"PeriodicalIF":2.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432934/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10405639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does Head Tilt Influence Facial Appearance More Than Head Turn? 头部倾斜比头部转动对面部的影响更大?
IF 2 Q3 OPHTHALMOLOGY Pub Date : 2023-07-01 DOI: 10.18502/jovr.v18i3.13778
Mohamad Reza Akbari, Masoud Khorrami-Nejad, Haleh Kangari, Mohsen Heirani, Alireza Akbarzadeh Baghban, Kiana Raeesdana, Babak Masoomian

Purpose: To evaluate the frequency of facial asymmetry parameters in patients with head tilt versus those with head turn.

Methods: This cross-sectional comparative study was performed on 155 cases, including 58 patients with congenital pure head turn due to Duane retraction syndrome (DRS), 33 patients with congenital pure head tilt due to upshoot in adduction or DRS, and 64 orthotropic subjects as the control group. The facial appearance was evaluated by computerized analysis of digital photographs of patients' faces. Relative facial size (the ratio of the distance between the external canthus and the corner of the lips of both face sides) and facial angle (the angular difference between a line that connects two external canthi and another line that connects the two corners of the lips) measured as quantitative facial parameters. Qualitative parameters were evaluated by the presence of one-sided face, cheek, and nostril compression; and columella deviation.

Results: The facial asymmetry frequency in patients with head tilt, head turn, and orthotropic subjects was observed in 32 (97%), 50 (86.2%), and 22 (34.3%), respectively (P < 0.001). In patients with head tilt and head turn, the mean facial angle was 1.78º ± 1.01º and 1.19º ± 0.84º, respectively (P = 0.004) and the mean relative facial size was 1.027 ± 0.018 and 1.018 ± 0.014, respectively (P = 0.018). The frequencies of one-sided nostril compression, cheek compression, face compression, and columella deviation in patients with pure head tilt were found in 19 (58%), 21 (64%), 19 (58%), and 19 (58%) patients, respectively, and in patients with pure head turn the frequencies were observed in 42 (72%), 37 (63%), 27 (47%), and 43 (74%), respectively. All quantitative and qualitative facial asymmetry parameters and facial asymmetry frequencies were significantly higher in head tilt and head turn patients as compared to the control group (P < 0.001).

Conclusion: All facial asymmetry parameters in patients with head tilt and head turn were significantly higher than orthotropic subjects. The quantitative parameters such as relative facial size and facial angle were significantly higher in patients with pure head tilt than pure head turn. The results revealed that pure head tilt was associated with a higher prevalence of facial asymmetry than pure head turn.

目的:评价头部倾斜患者与头部转动患者面部不对称参数的频率。方法:对155例患者进行横断面对比研究,其中58例因Duane后缩综合征(DRS)导致先天性单纯头偏,33例因内收或DRS上翘导致先天性单纯头偏,64例为对照组。通过对患者面部数码照片的计算机分析来评估面部外观。相对面部尺寸(面部两侧外眼角与唇角之间的距离之比)和面部角度(连接两个外眼角的一条线与连接两个唇角的另一条线之间的角差)作为定量面部参数测量。通过单侧面部、脸颊和鼻孔压迫的存在来评估定性参数;和小柱偏差。结果:头部倾斜、头部转动和正向异性患者的面部不对称频率分别为32例(97%)、50例(86.2%)和22例(34.3%)(P < 0.001)。头部倾斜和头部转动患者的平均面部角度分别为1.78º±1.01º和1.19º±0.84º(P = 0.004),平均相对面部尺寸分别为1.027±0.018和1.018±0.014 (P = 0.018)。单纯头部倾斜患者出现单侧鼻孔压迫、脸颊压迫、面部压迫和小柱偏离的频率分别为19例(58%)、21例(64%)、19例(58%)和19例(58%),单纯头部倾斜患者出现单侧鼻孔压迫、脸颊压迫、面部压迫和小柱偏离的频率分别为42例(72%)、37例(63%)、27例(47%)和43例(74%)。与对照组相比,头部倾斜和头部转动患者的所有定量和定性面部不对称参数和面部不对称频率均显著升高(P < 0.001)。结论:头部倾斜和头部转动患者面部各不对称参数均显著高于正异性患者。单纯头部倾斜患者的相对面部大小、面部角度等定量参数明显高于单纯头部转动患者。结果显示,单纯的头部倾斜比单纯的头部转动更容易导致面部不对称。
{"title":"Does Head Tilt Influence Facial Appearance More Than Head Turn?","authors":"Mohamad Reza Akbari,&nbsp;Masoud Khorrami-Nejad,&nbsp;Haleh Kangari,&nbsp;Mohsen Heirani,&nbsp;Alireza Akbarzadeh Baghban,&nbsp;Kiana Raeesdana,&nbsp;Babak Masoomian","doi":"10.18502/jovr.v18i3.13778","DOIUrl":"https://doi.org/10.18502/jovr.v18i3.13778","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the frequency of facial asymmetry parameters in patients with head tilt versus those with head turn.</p><p><strong>Methods: </strong>This cross-sectional comparative study was performed on 155 cases, including 58 patients with congenital pure head turn due to Duane retraction syndrome (DRS), 33 patients with congenital pure head tilt due to upshoot in adduction or DRS, and 64 orthotropic subjects as the control group. The facial appearance was evaluated by computerized analysis of digital photographs of patients' faces. Relative facial size (the ratio of the distance between the external canthus and the corner of the lips of both face sides) and facial angle (the angular difference between a line that connects two external canthi and another line that connects the two corners of the lips) measured as quantitative facial parameters. Qualitative parameters were evaluated by the presence of one-sided face, cheek, and nostril compression; and columella deviation.</p><p><strong>Results: </strong>The facial asymmetry frequency in patients with head tilt, head turn, and orthotropic subjects was observed in 32 (97%), 50 (86.2%), and 22 (34.3%), respectively (<i>P</i> <math><mo><</mo></math> 0.001). In patients with head tilt and head turn, the mean facial angle was 1.78º <math><mo>±</mo></math> 1.01º and 1.19º <math><mo>±</mo></math> 0.84º, respectively (<i>P</i> = 0.004) and the mean relative facial size was 1.027 <math><mo>±</mo></math> 0.018 and 1.018 <math><mo>±</mo></math> 0.014, respectively (<i>P</i> = 0.018). The frequencies of one-sided nostril compression, cheek compression, face compression, and columella deviation in patients with pure head tilt were found in 19 (58%), 21 (64%), 19 (58%), and 19 (58%) patients, respectively, and in patients with pure head turn the frequencies were observed in 42 (72%), 37 (63%), 27 (47%), and 43 (74%), respectively. All quantitative and qualitative facial asymmetry parameters and facial asymmetry frequencies were significantly higher in head tilt and head turn patients as compared to the control group (<i>P</i> <math><mo><</mo></math> 0.001).</p><p><strong>Conclusion: </strong>All facial asymmetry parameters in patients with head tilt and head turn were significantly higher than orthotropic subjects. The quantitative parameters such as relative facial size and facial angle were significantly higher in patients with pure head tilt than pure head turn. The results revealed that pure head tilt was associated with a higher prevalence of facial asymmetry than pure head turn.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 3","pages":"297-305"},"PeriodicalIF":2.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432935/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10050023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgically Managed Orbital Tumors: A Case Series from a Referral Center in Iran. 手术治疗眼眶肿瘤:来自伊朗转诊中心的病例系列。
IF 1.6 Q3 OPHTHALMOLOGY Pub Date : 2023-04-19 eCollection Date: 2023-04-01 DOI: 10.18502/jovr.v18i2.13178
Arman Mashayekhi
{"title":"Surgically Managed Orbital Tumors: A Case Series from a Referral Center in Iran.","authors":"Arman Mashayekhi","doi":"10.18502/jovr.v18i2.13178","DOIUrl":"10.18502/jovr.v18i2.13178","url":null,"abstract":"","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 2","pages":"141-142"},"PeriodicalIF":1.6,"publicationDate":"2023-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172801/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9839598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pachychoroid Spectrum Disorders: An Updated Review. 蛛网膜谱系障碍:最新综述。
IF 1.6 Q3 OPHTHALMOLOGY Pub Date : 2023-04-19 eCollection Date: 2023-04-01 DOI: 10.18502/jovr.v18i2.13188
Richard B Brown, Sashwanthi Mohan, Jay Chhablani

Pachychoroid disease spectrum is a recent term that has been associated with an increasing number of phenotypes. This review discusses updated findings for each of the typical pachychoroid entities (central serous chorioretinopathy, pachychoroid pigment epitheliopathy, pachychoroid neovasculopathy, polypoidal choroidal vasculopathy, peripapillary pachychoroid syndrome, and focal choroidal excavation), as well as two relatively new additions (peripapillary pachychoroid neovasculopathy and peripheral exudative hemorrhagic chorioretinopathy). Here, we discuss the potential pathogenic mechanisms for these diseases and relevant imaging updates. Finally, we argue for a consistent classification scheme for these entities.

蛛网膜疾病谱是一个新近出现的术语,与越来越多的表型相关。本综述讨论了每种典型脉络膜疾病(中央浆液性脉络膜视网膜病变、脉络膜色素上皮病变、脉络膜新生血管病变、多形性脉络膜血管病变、毛细血管周围脉络膜综合征和局灶性脉络膜挖空)的最新研究结果、此外,还有两个相对较新的新增病种(毛细血管周围蛛网膜新生血管病和外周渗出性出血性脉络膜视网膜病变)。在此,我们将讨论这些疾病的潜在致病机制和相关的最新成像技术。最后,我们主张为这些疾病制定一致的分类方案。
{"title":"Pachychoroid Spectrum Disorders: An Updated Review.","authors":"Richard B Brown, Sashwanthi Mohan, Jay Chhablani","doi":"10.18502/jovr.v18i2.13188","DOIUrl":"10.18502/jovr.v18i2.13188","url":null,"abstract":"<p><p>Pachychoroid disease spectrum is a recent term that has been associated with an increasing number of phenotypes. This review discusses updated findings for each of the typical pachychoroid entities (central serous chorioretinopathy, pachychoroid pigment epitheliopathy, pachychoroid neovasculopathy, polypoidal choroidal vasculopathy, peripapillary pachychoroid syndrome, and focal choroidal excavation), as well as two relatively new additions (peripapillary pachychoroid neovasculopathy and peripheral exudative hemorrhagic chorioretinopathy). Here, we discuss the potential pathogenic mechanisms for these diseases and relevant imaging updates. Finally, we argue for a consistent classification scheme for these entities.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 2","pages":"212-229"},"PeriodicalIF":1.6,"publicationDate":"2023-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172805/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9470867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inverted ILM Flap Technique in Optic Disc Pit Maculopathy. 视盘凹陷黄斑病变中的倒置ILM瓣技术
IF 2 Q3 OPHTHALMOLOGY Pub Date : 2023-04-19 eCollection Date: 2023-04-01 DOI: 10.18502/jovr.v18i2.13189
Ali Tavallali, Yasaman Sadeghi, Seyed-Hossein Abtahi, Hosein Nouri, Sanam Samadikhadem, Mitra Rezaei, Mehdi Mazloumi

Purpose: To present the outcome of optic disc pit maculopathy (ODPM) managed successfully with an inverted internal limiting membrane (ILM) flap over the optic disc. A narrative review of ODPM pathogenesis and surgical management techniques are also provided.

Case report: This prospective interventional case series included three eyes of three adult patients (25-39 years old) with unilateral ODPM and a mean duration of unilaterally decreased visual acuity of 7.33 ± 2.40 months (4-12 months). The pars plana vitrectomy with posterior vitreous detachment induction was performed on eyes, followed by an inverted ILM flap insertion over the optic disc and gas tamponade. Patients were followed for 7-16 weeks postoperatively; best-corrected visual acuity (BCVA) improved dramatically in one patient from 2/200 to 20/25. BCVA in other patients improved two and three lines - to 20/50 and 20/30, respectively. A significant anatomical improvement was achieved in all three eyes, and no complication was detected throughout the follow-up period.

Conclusion: Vitrectomy with inverted ILM flap insertion over the optic disc is safe and can yield favorable anatomical improvement in patients with ODPM.

目的:介绍用倒置的视盘内缘膜(ILM)瓣成功治疗视盘凹陷性黄斑病变(ODPM)的结果。病例报告:该前瞻性介入病例系列包括三位成年患者(25-39 岁)的三只眼睛,他们都患有单侧 ODPM,单侧视力下降的平均持续时间为 7.33 ± 2.40 个月(4-12 个月)。对患者眼球进行玻璃体旁切除术并诱导玻璃体后脱离,然后在视盘上插入倒置的ILM瓣并进行气体填塞。术后对患者进行了 7-16 周的随访;其中一名患者的最佳矫正视力(BCVA)从 2/200 显著提高到 20/25。其他患者的最佳矫正视力(BCVA)分别提高了两行和三行,达到了 20/50 和 20/30。所有三只眼睛的解剖结构都有明显改善,在整个随访期间未发现并发症:结论:在视盘上插入倒置的ILM瓣进行玻璃体切除术是安全的,并能使ODPM患者的视力得到良好的改善。
{"title":"Inverted ILM Flap Technique in Optic Disc Pit Maculopathy.","authors":"Ali Tavallali, Yasaman Sadeghi, Seyed-Hossein Abtahi, Hosein Nouri, Sanam Samadikhadem, Mitra Rezaei, Mehdi Mazloumi","doi":"10.18502/jovr.v18i2.13189","DOIUrl":"10.18502/jovr.v18i2.13189","url":null,"abstract":"<p><strong>Purpose: </strong>To present the outcome of optic disc pit maculopathy (ODPM) managed successfully with an inverted internal limiting membrane (ILM) flap over the optic disc. A narrative review of ODPM pathogenesis and surgical management techniques are also provided.</p><p><strong>Case report: </strong>This prospective interventional case series included three eyes of three adult patients (25-39 years old) with unilateral ODPM and a mean duration of unilaterally decreased visual acuity of 7.33 <math><mo>±</mo></math> 2.40 months (4-12 months). The pars plana vitrectomy with posterior vitreous detachment induction was performed on eyes, followed by an inverted ILM flap insertion over the optic disc and gas tamponade. Patients were followed for 7-16 weeks postoperatively; best-corrected visual acuity (BCVA) improved dramatically in one patient from 2/200 to 20/25. BCVA in other patients improved two and three lines - to 20/50 and 20/30, respectively. A significant anatomical improvement was achieved in all three eyes, and no complication was detected throughout the follow-up period.</p><p><strong>Conclusion: </strong>Vitrectomy with inverted ILM flap insertion over the optic disc is safe and can yield favorable anatomical improvement in patients with ODPM.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 2","pages":"230-239"},"PeriodicalIF":2.0,"publicationDate":"2023-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172795/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9822864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eye Care in Young Children: A Parents' Perspective of Access and Barriers. 幼儿眼保健:家长视角下的可及性与障碍
IF 2 Q3 OPHTHALMOLOGY Pub Date : 2023-04-01 DOI: 10.18502/jovr.v18i2.13186
Ali M Alsaqr

Purpose: To evaluate parental perspectives of accessing eye care for children aged under seven years.

Methods: The survey was conducted during September 2020 to March 2021 using online applications and distributed to parents whose children were between the ages of three and seven years. The survey included parents' background, their knowledge of the provision of eye-care services, and the possible barriers that existed to access eye-care services. The relationship between parents' knowledge, barrier scores, level of parental education, and demographic or socioeconomic status was assessed using nonparametric tests.

Results: In total, 1037 questionnaires were completed. The respondents were from 50 cities across Saudi regions. The participants' age was 39 ± 7.5 years, and 54% of them had at least one child under the age of seven (n = 564). Further, 47% had not taken their children for vision screening at reception/year one (n = 467). In addition, 65% of them were not aware of the mandatory screening program at reception/year 1; whereas, only 20% (n = 207) knew how to access eye-care services; and only 39% of the children had undergone any kind of eye or vision test. The pathways to eye care and the cost of eye services/glasses were the main limitations. The parents' responses were significantly influenced by their demographic and socioeconomic characteristics (Kruskal Wallis, P < 0.05).

Conclusion: There was a need for enhancing parent information on how to access eye care for young children and the currently available vision screening programs. Finally, a national protocol to cover the cost of the eye exam as well as spectacle prescription shall be proposed as a mean of incentive.

目的:评价7岁以下儿童获得眼保健的家长观点。方法:调查于2020年9月至2021年3月通过在线申请进行,并分发给子女年龄在3至7岁之间的父母。调查内容包括家长的背景、他们对提供眼科护理服务的了解程度,以及可能存在的妨碍获得眼科护理服务的障碍。使用非参数检验评估父母知识、障碍分数、父母教育水平与人口或社会经济地位之间的关系。结果:共完成问卷1037份。受访者来自沙特地区的50个城市。参与者年龄为39±7.5岁,54%的参与者至少有一个7岁以下的孩子(n = 564)。此外,47%的人在接待时没有带孩子进行视力筛查(n = 467)。此外,65%的人不知道在接待/第一年的强制性筛查程序;然而,只有20% (n = 207)知道如何获得眼科护理服务;只有39%的孩子接受了任何类型的眼睛或视力测试。获得眼科保健的途径和眼科服务/眼镜的费用是主要的限制。父母的人口学特征和社会经济特征显著影响父母的回答(Kruskal Wallis, P 0.05)。结论:有必要加强对如何获得幼儿眼睛保健和现有视力筛查方案的家长信息。最后,应提出一项国家协议,以支付眼科检查和眼镜处方的费用,作为一种激励手段。
{"title":"Eye Care in Young Children: A Parents' Perspective of Access and Barriers.","authors":"Ali M Alsaqr","doi":"10.18502/jovr.v18i2.13186","DOIUrl":"https://doi.org/10.18502/jovr.v18i2.13186","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate parental perspectives of accessing eye care for children aged under seven years.</p><p><strong>Methods: </strong>The survey was conducted during September 2020 to March 2021 using online applications and distributed to parents whose children were between the ages of three and seven years. The survey included parents' background, their knowledge of the provision of eye-care services, and the possible barriers that existed to access eye-care services. The relationship between parents' knowledge, barrier scores, level of parental education, and demographic or socioeconomic status was assessed using nonparametric tests.</p><p><strong>Results: </strong>In total, 1037 questionnaires were completed. The respondents were from 50 cities across Saudi regions. The participants' age was 39 <math><mo>±</mo></math> 7.5 years, and 54% of them had at least one child under the age of seven (<i>n</i> = 564). Further, 47% had not taken their children for vision screening at reception/year one (<i>n</i> = 467). In addition, 65% of them were not aware of the mandatory screening program at reception/year <i>1</i>; whereas, only 20% (<i>n</i> = 207) knew how to access eye-care services; and only 39% of the children had undergone any kind of eye or vision test. The pathways to eye care and the cost of eye services/glasses were the main limitations. The parents' responses were significantly influenced by their demographic and socioeconomic characteristics (Kruskal Wallis, <i>P</i> <math><mo><</mo></math> 0.05).</p><p><strong>Conclusion: </strong>There was a need for enhancing parent information on how to access eye care for young children and the currently available vision screening programs. Finally, a national protocol to cover the cost of the eye exam as well as spectacle prescription shall be proposed as a mean of incentive.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 2","pages":"192-201"},"PeriodicalIF":2.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172806/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9523705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Phacoemulsification on Intraocular Pressure in Eyes with Functioning Tube Shunts. 超声乳化术对正常分流眼眼压的影响。
IF 2 Q3 OPHTHALMOLOGY Pub Date : 2023-04-01 DOI: 10.18502/jovr.v18i2.13180
Wesam Shamseldin Shalaby, Sonali Patel, Sophia S Lam, Allen Ganjei, Aakriti Garg Shukla, Natasha Kolomeyer, Daniel Lee, L Jay Katz, Marlene R Moster, Jonathan Myers, Reza Razeghinejad

Purpose: To evaluate the effect of phacoemulsification on intraocular pressure (IOP) in eyes with functioning tube shunts.

Methods: This was a retrospective chart review of primary open-angle glaucoma (POAG) patients with a functioning tube who underwent phacoemulsification and had 24 months of follow-up. The primary end point was defined as surgical failure (IOP > 21 mmHg) at month 24, progression to no light perception (NLP) vision, glaucoma reoperation, or implant removal. Surgical failure defined as IOP >18 and >15 mmHg, changes in visual acuity (VA), IOP, and number of medications were assessed.

Results: Twenty-seven eyes of 27 patients with moderate or severe POAG were included. The mean age of the patients was 64.2 ± 10.8 years. The interval between the tube shunt and phacoemulsification was 28.8 ± 25.0 months. At the end of the study, four (14.8%) eyes met the failure criteria; the average time to failure was 9.3 ± 3.8 months. The causes of failure were high IOP in two (50.0%) and glaucoma reoperation in two (50.0%) eyes; however, no eyes progressed to NLP vision. Surgical failure defined as IOP >18 and >15 mmHg showed an increasing failure rate (18.5% and 48.5%, respectively).Themean IOP and medications number remained stable at month 24 compared to baseline (P = 0.131 and P = 0.302, respectively). Initially, VA showed improvement, with the greatest improvement at 6 months (P = 0.001), but at 24 months the improvement was no longer significant (P = 0.430).

Conclusion: Phacoemulsification in patients with functioning tubes did not change the mean IOP in most of the patients (86.2%); the number of medications also did not increase.

目的:探讨超声乳化术对正常分流眼眼压的影响。方法:回顾性分析原发开角型青光眼(POAG)患者行超声乳化术,随访≥24个月。主要终点定义为第24个月手术失败(IOP > 21 mmHg),进展为无光感(NLP)视力,青光眼再手术或植入物移除。手术失败定义为IOP >18和>15 mmHg,视力(VA)、IOP和药物数量的变化进行评估。结果:纳入27例中重度POAG患者27只眼。患者平均年龄64.2±10.8岁。输卵管分流至超声乳化手术的时间间隔为28.8±25.0个月。研究结束时,4只(14.8%)眼符合失效标准;平均失效时间为9.3±3.8个月。失败原因为高IOP 2例(50.0%),青光眼再手术2例(50.0%);然而,没有眼睛进展到NLP视力。手术失败定义为IOP >18和>15 mmHg,失败率增加(分别为18.5%和48.5%)。与基线相比,平均IOP和药物数量在第24个月保持稳定(P = 0.131和P = 0.302)。最初,VA表现出改善,在6个月时改善最大(P = 0.001),但在24个月时改善不再显著(P = 0.430)。结论:输卵管功能正常的患者行超声乳化术后,大多数患者(86.2%)的平均IOP未发生改变;药物的数量也没有增加。
{"title":"Effect of Phacoemulsification on Intraocular Pressure in Eyes with Functioning Tube Shunts.","authors":"Wesam Shamseldin Shalaby,&nbsp;Sonali Patel,&nbsp;Sophia S Lam,&nbsp;Allen Ganjei,&nbsp;Aakriti Garg Shukla,&nbsp;Natasha Kolomeyer,&nbsp;Daniel Lee,&nbsp;L Jay Katz,&nbsp;Marlene R Moster,&nbsp;Jonathan Myers,&nbsp;Reza Razeghinejad","doi":"10.18502/jovr.v18i2.13180","DOIUrl":"https://doi.org/10.18502/jovr.v18i2.13180","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the effect of phacoemulsification on intraocular pressure (IOP) in eyes with functioning tube shunts.</p><p><strong>Methods: </strong>This was a retrospective chart review of primary open-angle glaucoma (POAG) patients with a functioning tube who underwent phacoemulsification and had <math><mo>≥</mo></math>24 months of follow-up. The primary end point was defined as surgical failure (IOP <math><mo>></mo></math> 21 mmHg) at month 24, progression to no light perception (NLP) vision, glaucoma reoperation, or implant removal. Surgical failure defined as IOP <math><mo>></mo></math>18 and <math><mo>></mo></math>15 mmHg, changes in visual acuity (VA), IOP, and number of medications were assessed.</p><p><strong>Results: </strong>Twenty-seven eyes of 27 patients with moderate or severe POAG were included. The mean age of the patients was 64.2 <math><mo>±</mo></math> 10.8 years. The interval between the tube shunt and phacoemulsification was 28.8 <math><mo>±</mo></math> 25.0 months. At the end of the study, four (14.8%) eyes met the failure criteria; the average time to failure was 9.3 <math><mo>±</mo></math> 3.8 months. The causes of failure were high IOP in two (50.0%) and glaucoma reoperation in two (50.0%) eyes; however, no eyes progressed to NLP vision. Surgical failure defined as IOP <math><mo>></mo></math>18 and <math><mo>></mo></math>15 mmHg showed an increasing failure rate (18.5% and 48.5%, respectively).Themean IOP and medications number remained stable at month 24 compared to baseline (<i>P</i> = 0.131 and <i>P</i> = 0.302, respectively). Initially, VA showed improvement, with the greatest improvement at 6 months (<i>P</i> = 0.001), but at 24 months the improvement was no longer significant (<i>P</i> = 0.430).</p><p><strong>Conclusion: </strong>Phacoemulsification in patients with functioning tubes did not change the mean IOP in most of the patients (86.2%); the number of medications also did not increase.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 2","pages":"150-156"},"PeriodicalIF":2.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9470868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Ophthalmic & Vision Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1